Genmab | GEN - Sales Revenues

Stock Price
1,726.50
Daily Change
12.00 0.70%
Monthly
-5.40%
Yearly
24.30%
Q1 Forecast
1,614.31

Genmab reported DKK5.86B in Sales Revenues for its fiscal quarter ending in June of 2025.





Sales Change Date
Agios Pharmaceuticals USD 19.97M 7.07M Dec/2025
Almirall EUR 547.63M 12.83M Dec/2025
Amarin USD 49.67M 23.07M Sep/2025
Amgen USD 9.9B 340M Dec/2025
argenx SE USD 1.12B 132.91M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
BioMarin Pharmaceutical USD 875M 99M Dec/2025
Demant DKK 6.26B 810M Dec/2025
Exelixis USD 598.66M 860K Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GN Store Nord DKK 4.68B 720M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Insmed USD 263.8M 121.8M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
UCB EUR 3.49B 129M Jun/2025